UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059991
Receipt number R000068585
Scientific Title Effects of neuromuscular electrical stimulation on quadriceps muscle thickness after anterior cruciate ligament reconstruction using quadriceps tendon: a prospective randomized controlled trial
Date of disclosure of the study information 2025/12/05
Last modified on 2025/12/05 14:32:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

How electrical muscle stimulation affects quadriceps muscle thickness in patients after anterior cruciate ligament reconstruction using quadriceps tendon?

Acronym

Effect of electrical muscle stimulation on quadriceps muscle thickness in patients after ACL reconstruction using quadriceps tendon

Scientific Title

Effects of neuromuscular electrical stimulation on quadriceps muscle thickness after anterior cruciate ligament reconstruction using quadriceps tendon: a prospective randomized controlled trial

Scientific Title:Acronym

Effect of EMS on quadriceps muscle thickness after ACL reconstruction using QT autograft: a prospective randomized controlled trial

Region

Japan


Condition

Condition

Anterior cruciate ligament injury

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In patients who undergo anterior cruciate ligament reconstruction using quadriceps tendon, postoperative recovery of knee extensor strength is often insufficient, potentially delaying safe and early return to sports. The aim of this study is to examine, in a prospective randomized controlled trial, whether electrical muscle stimulation of the quadriceps modifies quadriceps muscle thickness after ACL reconstruction using quadriceps tendon.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in quadriceps muscle thickness according to the presence or absence of electrical muscle stimulation (thickness of the rectus femoris, vastus lateralis, vastus medialis, and vastus intermedius measured by ultrasonography preoperatively and at 3 and 6 months postoperatively, and the change in muscle thickness at each time point compared between the intervention and control groups).

Key secondary outcomes

Lower limb muscle strength


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Standard postoperative physical therapy program after anterior cruciate ligament reconstruction plus electrical muscle stimulation applied to the quadriceps muscle.

Interventions/Control_2

Standard postoperative physical therapy program after anterior cruciate ligament reconstruction.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

- Patients undergoing primary anterior cruciate ligament reconstruction
- Patients in whom a quadriceps tendon autograft is used for ACL reconstruction
- Patients who participated in sports activities before injury (Tegner Activity Level Scale > 6)

Key exclusion criteria

- Patients with multi-ligament knee injuries
- Patients who do not aim to return to sports
- Patients with a history of lower limb surgery or neuromuscular diseases

Target sample size

52


Research contact person

Name of lead principal investigator

1st name Yushin
Middle name
Last name Mizuno

Organization

Kanazawa University

Division name

Section of Rehabilitation

Zip code

920-8641

Address

13-1, Takaramachi, Kanazawa, Ishikawa

TEL

076-265-2013

Email

mizuno@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Yushin
Middle name
Last name Mizuno

Organization

Kanazawa University

Division name

Section of Rehabilitation

Zip code

920-8641

Address

13-1, Takaramachi, Kanazawa, Ishikawa

TEL

076-265-2013

Homepage URL


Email

mizuno@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University

Institute

Department

Personal name



Funding Source

Organization

MTG Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanazawa University

Address

13-1, Takaramachi, Kanazawa Ishikawa

Tel

076-265-2110

Email

rinri@adm.kanazawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 06 Month 10 Day

Date of IRB

2024 Year 12 Month 19 Day

Anticipated trial start date

2025 Year 12 Month 05 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 05 Day

Last modified on

2025 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068585